OTCMKTS:PZRXQ

PhaseRx Stock Forecast, Price & News

$0.03
+0.02 (+177.17 %)
(As of 04/12/2021 12:21 PM ET)
Add
Compare
Today's Range
$0.03
Now: $0.03
$0.03
50-Day Range
$0.01
MA: $0.03
$0.04
52-Week Range
$0.00
Now: $0.03
$0.08
Volume232 shs
Average Volume38,182 shs
Market Capitalization$298,095.00
P/E RatioN/A
Dividend YieldN/A
Beta-0.86
PhaseRx, Inc., a biopharmaceutical company, engages in developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy. The company develops its products based on its proprietary Hybrid mRNA technology platform, which allows the synthesis of missing enzyme inside the cell. Its therapeutic urea cycle disorder programs under development include PRX-OTC to treat ornithine transcarbamylase deficiency; PRX-ASL to treat argininosuccinate lyase deficiency; and PRX-ASS1 to treat argininosuccinate synthetase deficiency. The company was incorporated in 2006 and is headquartered in Seattle, Washington.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PZRXQ
CUSIPN/A
CIKN/A
Phone206-805-6300
Employees10
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$298,095.00
Next Earnings DateN/A
OptionableNot Optionable

Headlines

No headlines for this company have been tracked by MarketBeat.com

MarketRank

Overall MarketRank

0.17 out of 5 stars

Medical Sector

1809th out of 2,016 stocks

Pharmaceutical Preparations Industry

724th out of 771 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -
$0.03
+0.02 (+177.17 %)
(As of 04/12/2021 12:21 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PZRXQ News and Ratings via Email

Sign-up to receive the latest news and ratings for PZRXQ and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











PhaseRx (OTCMKTS:PZRXQ) Frequently Asked Questions

What stocks does MarketBeat like better than PhaseRx?

Wall Street analysts have given PhaseRx a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but PhaseRx wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting PhaseRx?

PhaseRx saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 100 shares, a drop of 93.3% from the March 15th total of 1,500 shares. Based on an average daily volume of 15,000 shares, the days-to-cover ratio is currently 0.0 days.
View PhaseRx's Short Interest
.

Who are PhaseRx's key executives?

PhaseRx's management team includes the following people:
  • Dr. Robert W. Overell, Co-Founder, CEO, Pres, Principal Accounting Officer, Sec. & Director (Age 65, Pay $487.17k)
  • Dr. Paul H. Johnson Ph.D., Co-Founder & Director (Age 78, Pay $33.12k)
  • Prof. Allan S. Hoffman, Co-Founder
  • Dr. Patrick S. Stayton Ph.D., Co-Founder
  • Dr. Oliver W. Press M.D., Ph.D., Co-Founder
  • Dr. Mary G. Prieve Ph.D., VP of Biology & Interim Head of Research
  • Mr. Spencer Lemons, Head of Bus. Devel.

Who are some of PhaseRx's key competitors?

What is PhaseRx's stock symbol?

PhaseRx trades on the OTCMKTS under the ticker symbol "PZRXQ."

How do I buy shares of PhaseRx?

Shares of PZRXQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PhaseRx's stock price today?

One share of PZRXQ stock can currently be purchased for approximately $0.03.

How much money does PhaseRx make?

PhaseRx has a market capitalization of $298,095.00.

How many employees does PhaseRx have?

PhaseRx employs 10 workers across the globe.

What is PhaseRx's official website?

The official website for PhaseRx is www.phaserx.com.

Where are PhaseRx's headquarters?

PhaseRx is headquartered at 410 W. Harrison Street Suite 300, Seattle WA, 98119.

How can I contact PhaseRx?

PhaseRx's mailing address is 410 W. Harrison Street Suite 300, Seattle WA, 98119. The company can be reached via phone at 206-805-6300 or via email at [email protected]


This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.